SonoVol

About:

SonoVol is a developer of a fully-automated benchtop ultrasound platform.

Website: https://sonovol.com/

Twitter/X: SonoVol

Top Investors: National Science Foundation, One North Carolina Small Business Program

Description:

SonoVol is a developer of a fully-automated benchtop ultrasound platform designed to lower the barrier of entry for every biologist that needs to perform preclinical screening or acquire longitudinal in vivo data in the pharmaceutical, biotech, government and academic markets. The company's platform permits researchers to rapidly determine tumor size, location, morphology and vascular density and the precise movement of the transducer through robotic motion control contributes to standardized results with every study, regardless of user, enabling researchers and clinicians to detect and treat tumor effectively.

Total Funding Amount:

$1.22M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2012-01-01

Founders:

Paul Dayton, Ryan Gessner

Number of Employees:

1-10

Last Funding Date:

2021-02-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai